WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months

WCLC 2023 |Dr. Zhu Zhengfei: SBRT Combined with Dual Immune Checkpoint Inhibitors for Advanced NSCLC Achieves a Median OS of 34 Months

The 2023 World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), was held in Singapore from September 9th to 12th. " Oncology Frontier" invited Zhu Zhengfei from Fudan University-affiliated Cancer Hospital to comment on the findings of the COSINR study.
The Value of Lepidic and Invasion Patterns New Diagnostic Criteria for the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma

The Value of Lepidic and Invasion Patterns New Diagnostic Criteria for the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma

At the 2023 World Conference on Lung Cancer (WCLC), Dr. Xie Huikang from Shanghai Pulmonary Hospital presented a study titled " The Value of Lepidic and Invasion Pattern NEW Diagnostic Criteria for the Differential Diagnosis of AIS, MIA from Invasive Adenocarcinoma ." The study aimed to explore whether the new IASLC definitions and standards had an impact on the diagnosis of AIS, MIA, and IAC compared to previous criteria.
WCLC Voice of China | Dr. Liang Application of Video-Based Artificial Intelligence in Thoracoscopic Lobectomy for Lung Cancer

WCLC Voice of China | Dr. Liang Application of Video-Based Artificial Intelligence in Thoracoscopic Lobectomy for Lung Cancer

From September 9th to 12th, 2023, the World Conference on Lung Cancer (WCLC) was held in Singapore. Oncology Frontier deeply engaged in the conference, capturing the latest advancements and witnessing the progress and strides made by China in the international oncology arena. Dr. Liang Hengrui of the First Affiliated Hospital of Guangzhou Medical University presented the results from Chinese researchers in the field of "Artificial Intelligence Application in Thoracoscopic Lobectomy for Lung Cancer" in a brief oral report at the 2023 WCLC.
WCLC 2023| Dr. Wang Jie Awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Award

WCLC 2023| Dr. Wang Jie Awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Award

The International Association for the Study of Lung Cancer (IASLC) annually presents several awards to clinical physicians and researchers who have made significant contributions to the treatment of lung cancer patients. Awardees are invited to receive their awards at the World Conference on Lung Cancer (WCLC) and give speeches in their respective fields. At the WCLC 2023 conference, these awards were presented for the first time in a dedicated plenary session titled "Plenary Session 2: IASLC Lectureship Award Presentations," jointly hosted by IASLC CEO Karen Kelly and IASLC President Heather Wakelee. The Lectureship awards are presented to members from various fields, including radiation oncology, medical oncology, small cell lung cancer, nursing/health, translational research, thoracic surgery, staging, and tobacco control. Dr. Wang Jie from the Cancer Hospital Chinese Academy of Medical Sciences was awarded the 2023 Small Cell Lung Cancer Heine H. Hansen Lectureship Award for her outstanding contributions to small cell lung cancer research and treatment.